COVID-19 Vaccines (2025-2026 Formula) for Use in the United States Beginning in Fall 2025
FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on May 22, 2025, to discuss and make recommendations on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United States beginning in the fall of 2025.
Recommend0 recommendationsPublished in US National Health Agency Sources